Zhang, Y., Hochster, H., Stein, S., & Lacy, J. (2015). Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: Single institution retrospective review of efficacy and toxicity. Exp Hematol Oncol.
Chicago Style CitationZhang, Yue, Howard Hochster, Stacey Stein, i Jill Lacy. "Gemcitabine Plus Nab-paclitaxel for Advanced Pancreatic Cancer After First-line FOLFIRINOX: Single Institution Retrospective Review of Efficacy and Toxicity." Exp Hematol Oncol 2015.
Cita MLAZhang, Yue, Howard Hochster, Stacey Stein, i Jill Lacy. "Gemcitabine Plus Nab-paclitaxel for Advanced Pancreatic Cancer After First-line FOLFIRINOX: Single Institution Retrospective Review of Efficacy and Toxicity." Exp Hematol Oncol 2015.